Date_of_Alert_
|
__Urgency__
|
Subject
|
|
05-03-2013
|
|
|
|
05-01-2013
|
Advisory |
|
| 04-16-2013 |
Advisory |
|
| 04-12-2013 |
Update |
|
| 04-05-2013 |
Advisory |
CDC Health Advisory: Human Infections with Novel Influenza A (H7N9) Viruses
The purpose of this advisory is to inform and provide guidance to health care providers in the evaluation of patients for novel Influenza A (H7N9) infection. Read the full advisory or go to the CDC Health Alert Network Page for additional advisories or updates. As of April 4, 2013, 14 cases of human infection with a novel avian influenza A (H7N9) virus were reported from four different provinces in China. All patients were hospitalized with severe respiratory illness and six persons died. These are the first human infections identified with an avian influenza A (H7N9). All illness onsets were from February 19 - March 31, 2013. No person-to-person transmission or epidemiologic link between any of the cases has been identified. Sources of infections are under investigation.
The CDC is not yet issuing any formal travel advisories. No cases of human infection with avian influenza A (H7N9) viruses have been detected in the United States. However, clinicians are reminded to consider influenza as a possible diagnosis when evaluating patients with acute respiratory illnesses, including pneumonia, even outside of the typical influenza season. Read the latest updates, case definitions, and guidance from the CDC on their website. In hospitalized patients or others at high risk of severe disease (i.e, age <5 or >=65 or underlying medical conditions), treatment with oral oseltamivir or inhaled zanamivir should be started as soon as possible, without waiting for laboratory confirmation. Preliminary information indicates the virus is susceptible to neuraminidase inhibitors.
Clinicians in San Francisco should implement appropriate infection control recommendations and contact the SFDPH/Communicable Disease Control Unit immediately at (415) 554-2830 to arrange testing for Novel Influenza A(H7N9) for suspected cases with a travel or exposure history.
|
| 03-08-2013 |
Advisory |
CDC Health Advisory: Updated Guidelines for Evaluation of Severe Respiratory Illness Associated with a Novel Coronavirus
The purpose of this Advisory is to provide guidance to health care providers in the evaluation of patients for novel coronavirus infection. Read the full advisory here or go to the CDC Health Alert Network Page for additional advisories or updates.
CDC does not recommend that anyone change their travel plans because of these cases of the novel coronavirus. CDC recommends that US travelers to countries in or near the Arabian Peninsula monitor their health and see a doctor right away if they develop fever and symptoms such as cough or shortness of breath. They should tell the doctor about their recent travel.
UPDATE: As of March 27, 2013, 17 laboratory-confirmed cases of Novel Coronavirus have been reported to WHO - from Saudi Arabia, Qatar, Jordan, United Arab Emirates and the United Kingdom. Among the 17 cases, eleven were fatal. Two of the 17 cases experienced a mild respiratory illness and fully recovered. Read the latest updates, case definitions, and guidance from the CDC. Doctors in San Francisco should contact the SFDPH/Communicable Disease Control Unit immediately at (415) 554-2830 to arrange testing for suspected cases.
|
| 03-04-2013 |
Update |
CDC Health Update (HAN): Notice to Clinicians: Continued Vigilance Urged for Fungal Infections among Patients Who Received Contaminated Steroid Injections
CDC is still receiving new reports of fungal infections among patients who were given injections of contaminated methylprednisolone acetate (MPA) from NECC. Most of these recent cases have been localized spinal or paraspinal infections in patients, although new cases of meningitis or arachnoiditis also have been reported. CDC is recommending that physicians seeing patients with mild or even baseline symptoms, consider evaluation with magnetic resonance imaging (MRI) if clinically warranted.
Read the full update here, or go to the CDC Health Alert Network Page for more updates.
NOTE: San Francisco Clinicians did not receive any of the contaminated medication.
|
| 01-11-2013 |
Advisory |
|
| 12-06-2012.... |
|
|
|
12-03-2012
|
Advisory |
|
|
12-03-2012
|
Update |
CDC Health Update (HAN): New England Compounding Center - Additional Contamination Identified
CDC and FDA identified additional microbial contamination in unopened vials of betamethasone, cardioplegia, and triamcinolone solutions distributed and recalled from NECC. Contamination includes bacteria known as Bacillus, and fungal species including Aspergillus tubingensis, Aspergillus fumigatus, Cladosporiumspecies, and Penicilliumspecies. Healthcare providers should remain alert for the possibility of infections from these medications.
Read the full CDC Health Update, and for updated information go to the FDA website.
|
|
11-07-2012
|
Advisory |
|
|
11-01-2012
|
Update |
Ameridose Voluntary Recall
Health Care professionals should stop using Ameridose products at this time, and return them to the firm.
The US Food and Drug Administration (FDA) recommended a recall of any unexpired Ameridose products remaining in circulation as of October 31, 2012 out of an abundance of caution. As of October 31, the recall is not based on reports of patients with infections associated with any of Ameridose's products. Therefore, at this time, the FDA is also recommending that health care professionals to not need to follow up with patients who received Ameridose products.
Please refer to the following websites for more information about the recall as information may be updated during the investigation:
|
| 10-09-2012 |
Alert |
|
| 09-24-2012 |
Update |
|
| 09-07-2012 |
Update |
|
| 06-12-2012 |
Update |
|
| 10-17-2011 |
Advisory |
|
| 03-17-2011 |
Advisory |
|
| 10-06-2010 |
Advisory |
|
| 08-04-2010 |
Update |
|
|
06-24-2010
|
Update |
|
| 05-06-2010 |
Alert |
|
| 02-22-2010 |
Alert |
|
| 02-19-2010 |
Advisory |
|
| 02-05-2010 |
Advisory |
|
| 01-21-2010 |
Advisory |
|
| 10-26-2009 |
Advisory
|
|
| 10-21-2009 |
Advisory |
|
| 07-06-2009 |
Advisory
|
|
| 06-24-2009 |
Alert |
|
| 06-02-2009 |
Advisory |
|
| 05-18-2009 |
Alert |
|
| 05-12-2009 |
Alert |
|
| 05-04-2009 |
Alert |
|
| 05-01-2009 |
Alert |
|
| 04-29-2009 |
Alert |
|
| 04-27-2009 |
Alert |
|
| 04-24-2009 |
Alert |
|
| 01-30-2009 |
Alert |
|
| 01-22-2009 |
Advisory |
|
| 10-30-2008 |
Advisory |
|
| 10-27-2008 |
Advisory |
|
| 10-14-2008 |
Update |
|
| 10-03-2008 |
Update |
|
| 07-17-2008 |
Advisory |
|
| 05-08-2008 |
Alert |
|
| 01-28-2008 |
Update |
|
| 01-18-2008 |
Advisory |
|
| 11-15-2007 |
Advisory |
|
| 08-27-2007 |
Update |
|
| 08-14-2007 |
Alert |
|
| 11-30-2006 |
Advisory |
|
| 10-26-2006 |
Update |
|
| 08-07-2006 |
Advisory |
|
| 06-02-2006 |
Alert |
|
| 05-09-2006 |
Update |
|
| 12-12-2005 |
Update |
|
| 11-17-2005 |
Alert |
|
| 11-08-2005 |
Advisory |
|
| 10-31-2005 |
Advisory |
|
| 09-09-2005 |
Advisory |
|
| 04-2005 |
Update |
|
| 02-24-2005 |
Update |
|
| 12-22-2004 |
Alert |
|
| 11-29-2004 |
Alert |
|
| 11-09-2004 |
Alert |
|
| 11-03-2004 |
Advisory |
|
| 08-03-2004 |
Alert |
|
| 02-09-2004 |
Advisory |
|
| 01-23-2004 |
Advisory |
|
| 03-18-2003 |
Advisory |
|